Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1986 Dec;41(12):914–918. doi: 10.1136/thx.41.12.914

Effect of monocrotaline ingestion on the distribution of protein and angiotensin converting enzyme activity in the rat lung.

D J Shale, M S Wiseman, W O Cookson
PMCID: PMC460539  PMID: 3035737

Abstract

The alveolar accumulation of protein and angiotensin converting enzyme activity was compared with the development of right ventricular hypertrophy in male rats after different periods of monocrotaline exposure. Total doses of monocrotaline were varied by dividing the animals into three groups in which ingestion was limited to three, seven, and 15 days. These groups were studied 21 days after the start of monocrotaline exposure and compared with a group treated continuously for 28 days. The total lung weight increased after three or more days of treatment, while after seven days there was significant alveolar accumulation of protein, which was paralleled by an increase in angiotensin converting enzyme activity in alveolar lavage fluid. Identical changes also occurred after 15 and 28 days of exposure to monocrotaline. Lung angiotensin converting enzyme activity was decreased after three days' ingestion of monocrotaline and did not alter further with longer periods of exposure. None of these effects of monocrotaline in the three and seven day treatment groups was associated with right ventricular hypertrophy, which occurred only in animals treated for 15 or more days. The effects of monocrotaline ingestion on the lung were dose related and had no causal relationship to the development of right ventricular hypertrophy.

Full text

PDF
914

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  2. Cookson W. O., Wiseman M. S., Shale D. J. Angiotensin converting enzyme and endotoxin induced lung damage in the mouse. Thorax. 1985 Oct;40(10):774–777. doi: 10.1136/thx.40.10.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Friedland J., Silverstein E. A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am J Clin Pathol. 1976 Aug;66(2):416–424. doi: 10.1093/ajcp/66.2.416. [DOI] [PubMed] [Google Scholar]
  4. Hollinger M. A., Giri S. N., Patwell S., Zuckerman J. E., Gorin A., Parsons G. Effect of acute lung injury on angiotensin converting enzyme in serum, lung lavage, and effusate. Am Rev Respir Dis. 1980 Feb;121(2):373–376. doi: 10.1164/arrd.1980.121.2.373. [DOI] [PubMed] [Google Scholar]
  5. Hollinger M. A., Patwell S. W., Zuckerman J. E., Gorin A. B., Parsons G., Giri S. N. Effect of paraquat on serum angiotensin converting enzyme. Am Rev Respir Dis. 1980 May;121(5):795–798. doi: 10.1164/arrd.1980.121.5.795. [DOI] [PubMed] [Google Scholar]
  6. Huxtable R., Ciaramitaro D., Eisenstein D. The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium. Mol Pharmacol. 1978 Nov;14(6):1189–1203. [PubMed] [Google Scholar]
  7. Huxtable R., Paplanus S., Laugharn J. The prevention of monocrotaline-induced right ventricular hypertrophy. Chest. 1977 Feb;71(2 Suppl):308–310. doi: 10.1378/chest.71.2_supplement.308. [DOI] [PubMed] [Google Scholar]
  8. Kay J. M., Harris P., Heath D. Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds. Thorax. 1967 Mar;22(2):176–179. doi: 10.1136/thx.22.2.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kay J. M., Keane P. M., Suyama K. L., Gauthier D. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension. Thorax. 1982 Feb;37(2):88–96. doi: 10.1136/thx.37.2.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kay J. M., Smith P., Heath D. Electron microscopy of Crotalaria pulmonary hypertension. Thorax. 1969 Sep;24(5):511–526. doi: 10.1136/thx.24.5.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kay J. M., Smith P., Heath D., Will J. A. Effects of phenobarbitone, cinnarizine, and zoxazolamine on the development of right ventricular hypertrophy and hypertensive pulmonary vascular disease in rats treated with monocrotaline. Cardiovasc Res. 1976 Mar;10(2):200–205. doi: 10.1093/cvr/10.2.200. [DOI] [PubMed] [Google Scholar]
  12. Keane P. M., Kay J. M. Lung angiotensin converting enzyme activity in monocrotaline pulmonary hypertension. Thorax. 1984 Feb;39(2):159–160. doi: 10.1136/thx.39.2.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Keane P. M., Kay J. M., Suyama K. L., Gauthier D., Andrew K. Lung angiotensin converting enzyme activity in rats with pulmonary hypertension. Thorax. 1982 Mar;37(3):198–204. doi: 10.1136/thx.37.3.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lafranconi W. M., Huxtable R. J. Changes in angiotensin-converting enzyme activity in lungs damaged by the pyrrolizidine alkaloid monocrotaline. Thorax. 1983 Apr;38(4):307–309. doi: 10.1136/thx.38.4.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Meyrick B., Gamble W., Reid L. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am J Physiol. 1980 Nov;239(5):H692–H702. doi: 10.1152/ajpheart.1980.239.5.H692. [DOI] [PubMed] [Google Scholar]
  16. Stockley R. A. Measurement of soluble proteins in lung secretions. Thorax. 1984 Apr;39(4):241–247. doi: 10.1136/thx.39.4.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sugita T., Hyers T. M., Dauber I. M., Wagner W. W., McMurtry I. F., Reeves J. T. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats. J Appl Physiol Respir Environ Exerc Physiol. 1983 Feb;54(2):371–374. doi: 10.1152/jappl.1983.54.2.371. [DOI] [PubMed] [Google Scholar]
  18. Valdivia E., Lalich J. J., Hayashi Y., Sonnad J. Alterations in pulmonary alveoli after a single injection of monocrotaline. Arch Pathol. 1967 Jul;84(1):64–76. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES